What is BAI?
Established in 2009 and headquartered in Hamilton, New Jersey, BAI specializes in the production of antioxidant infusion drinks. The company has carved out a niche in the health-conscious beverage sector. As a subsidiary of Keurig Dr Pepper, BAI benefits from the infrastructure and market reach of a major beverage conglomerate, while continuing to operate its distinct product line. Its operational history includes various rounds of private equity and debt financing, reflecting a consistent need for capital to fuel its growth and product development.
How much funding has BAI raised?
BAI has raised a total of $37M across 10 funding rounds:
Private Equity
$600K
Private Equity
$500K
Private Equity
$2.6M
Private Equity
$752K
Private Equity
$3M
Debt
$750K
Private Equity
$3.4M
Private Equity
$10M
Private Equity
$15M
Debt
$350K
Private Equity (2010): $600K, investors not publicly disclosed
Private Equity (2010): $500K, investors not publicly disclosed
Private Equity (2011): $2.7M, investors not publicly disclosed
Private Equity (2012): $752K, investors not publicly disclosed
Private Equity (2012): $3M, investors not publicly disclosed
Debt (2013): $750K, investors not publicly disclosed
Private Equity (2013): $3.4M, investors not publicly disclosed
Private Equity (2014): $10M, investors not publicly disclosed
Private Equity (2015): $15M featuring Dr Pepper Snapple Group
Debt (2020): $350K backed by PPP
Key Investors in BAI
Dr Pepper Snapple Group
Dr Pepper Snapple Group is a major player in the beverage industry, and its investment in BAI likely signifies a strategic alignment or partnership aimed at expanding its portfolio of innovative drink options.
What's next for BAI?
The recent major strategic investment signifies a pivotal moment for BAI, particularly given its status as a subsidiary of Keurig Dr Pepper. This infusion of capital, part of the overall $37M in financing, is likely earmarked for enhancing production capabilities, expanding distribution channels, and further innovating its product offerings. The strategic nature of the investment suggests a focus on synergistic growth within the Keurig Dr Pepper portfolio, potentially leading to increased market penetration and brand visibility. This capital injection will be instrumental in navigating the dynamic beverage industry and solidifying BAI's position.
See full BAI company page
